Neuraxis, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -58.8% | +85.6% | +178.4% | -56.6% | +316.1% | -36.3% | +133.9% | -18.5% | +10.9% | +36.6% | +14.3% | |
| – | -74.9% | +68.1% | +417.8% | -70.1% | +575.2% | -40.4% | +160.5% | -24.6% | +14.9% | +42.0% | +15.6% | |
| – | -89.7% | +4.1% | +2,059.3% | -85.2% | +1,317.1% | -45.8% | +198.6% | -26.9% | +13.4% | +42.6% | +17.6% | |
| – | -89.7% | +4.1% | +2,059.3% | -85.2% | +1,317.1% | -45.8% | +198.6% | -26.9% | +13.4% | +42.6% | +17.6% | |
| – | -44.7% | +23.7% | +62.5% | -64.3% | +365.1% | -0.4% | -47.3% | -15.6% | +80.4% | +96.7% | +12.4% | |
| – | -38.5% | -4.8% | +111.5% | -47.4% | +97.4% | -15.6% | +251.2% | -16.1% | +133.2% | -7.3% | +16.4% | |
| – | -2.4% | -2.4% | -2.5% | -3.5% | -2.6% | -2.7% | -2.8% | +209.9% | -2.9% | -3.0% | -3.1% | |
| – | -16.7% | +115.9% | +91.1% | -62.8% | -8.4% | +3.0% | +2.3% | +23.2% | -13.9% | -0.2% | +8.8% | |
| – | -16.5% | +102.4% | +99.0% | -64.9% | -8.7% | -13.6% | +11.7% | +34.1% | -11.3% | +0.8% | +10.0% | |
| – | -17.6% | +626.2% | +236.3% | -95.8% | +6.3% | -30.8% | +72.9% | -0.5% | -17.2% | -20.8% | -32.4% | |
| – | +112.5% | +2.7% | -9.6% | -14.0% | -38.0% | -10.4% | -13.2% | +90.8% | -84.3% | +119.1% | +159.3% | |
| – | – | – | – | – | – | -87.5% | +1,545.5% | -46.3% | +48.8% | +69.1% | +17.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -41.2% | +80.7% | +5.7% | +0.9% | -0.9% | +7.9% | +14.2% | +15.9% | -8.0% | +20.5% | +10.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.